Pharmaceutical Raw Material Dealers in Okhla, Delhi

• Form: Hard Gelatin Capsules
• Treatment: Cancer Treatment
• Dosage: As per Doctor's Prescription
• Storage: Cool and Dry Place
• Best Before: 36 Months from Manufacturing

A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Ceritinib blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Ceritinib is a type of tyrosine kinase inhibitor. Also called Zykadia. US Brand Name(s): Zykadia. FDA Approved: Yes   Ceritinib is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014.   Ceritinib is an anaplastic lymphoma kinase (ALK) inhibitor primarily used for the treatment of ALK positive metastatic NSCLC.[4][5] Previously, it was only indicated for patients who had developed resistant to crizotinib, another ALK inhibitor, but has since had its usage expanded to serve as a primary option for metastatic NSCLC.   Ceritinib is approved to treat: Non-small cell lung cancer that is ALK positive and has metastasized (spread to other parts of the body). It is used in adults.